Mordor Intelligence has published a new report on the Australia Pharmaceutical Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
-- Introduction
The Australia pharmaceutical market size reached USD 14.04 billion in 2025 and is forecast to expand at a 6.25% CAGR, lifting revenue to USD 19.01 billion by 2030 . These figures reflect rising demand driven by demographic pressures, increasing chronic disease burdens, and evolving government support mechanisms.
The australia pharmaceutical market is deeply shaped by the country’s public health architecture, notably the Pharmaceutical Benefits Scheme (PBS), which subsidises prescription drugs and helps maintain affordability and access across diverse patient populations . At the same time, regulatory pathways at the Therapeutic Goods Administration (TGA) that offer priority review for novel therapies are shortening approval timelines, encouraging firms to speed launches of high-value treatments.
Key Trends in the Australia Pharmaceutical Market
Rise of Specialty & Oncology Therapies
One of the strongest contributors to australia pharmaceutical market growth is the expansion of oncology and specialty therapies. Within the therapeutic class breakdown, oncology drugs are advancing more rapidly than many traditional segments, reflecting greater investment in cancer care and immunotherapies . Because these therapies typically command higher margins and demand more complex logistics, they are shifting portfolio mix and competitive focus in the market.
Strong Growth of Generics & Cost Containment
While branded, innovative therapies remain a growth engine, generic medicines continue to gain traction, especially among cost-conscious payers and patients. In 2024, prescription (Rx) medicines already captured more than 85 % of the market, but generic formulations are forecast to grow at a healthy clip over the forecast period . Because generics reduce cost burdens and enhance market reach, many manufacturers are strengthening their generic pipelines or licensing strategies.
Digital Dispensing, E-Pharmacy & Electronic Prescriptions
The digitalization of prescription flows is altering how medications are dispensed and delivered. Australia has processed hundreds of millions of electronic prescriptions since 2020, and hybrid or fully online pharmacy models are increasing in acceptance . That trend not only enhances patient adherence but also helps cut dispensing overheads—a factor that benefits both providers and pharmaceutical suppliers.
On-shoring & Supply Chain Resilience
Historically, Australia has depended heavily on imports for active pharmaceutical ingredients (APIs). However, recent government incentives and concerns over global supply disruptions are spurring investment into local manufacturing of injectables, biologics, and critical generics . Such reshoring helps reduce dependency risk and can shorten lead times, contributing to more resilient supply chains.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/australia-pharmaceutical-market?utm_source=marketersmedia
Market Segmentation in the Australia Pharmaceutical Market
Below is a detailed segmentation layout for the australia pharmaceutical market, showing how the market is structured and where growth is concentrated:
By Therapeutic / ATC Class
- Alimentary Tract & Metabolism
- Blood & Blood Forming Organs
- Cardiovascular System
- Dermatologicals
- Genito-Urinary & Sex Hormones
- Systemic Hormonal Preparations
- Anti-infectives for Systemic Use
- Antineoplastic & Immunomodulating Agents
- Other Therapeutic Classes
By Drug Type
- Branded (Innovator) Drugs
- Generic Drugs
By Formulation
- Tablets
- Capsules
- Injectables
- Others (Topicals, Patches, etc.)
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Key Players & Competitive Landscape in the Australia Pharmaceutical Market
- Abbvie Inc.
- Amgen Inc.
- AstraZeneca plc
- Eli Lilly & Co.
- Pfizer Inc.
Conclusion
In summary, the australia pharmaceutical market is projected to grow steadily from its base in 2025 to reach nearly USD 19 billion by 2030, as per Mordor Intelligence forecasts . That growth will be underpinned by demographic shifts toward older populations, rising chronic disease prevalence, and a healthcare funding model that supports accessible therapeutics through programs like the PBS.
Key trends—such as expansion in oncology and specialty therapies, stronger uptake of generics, digital dispensing, and supply chain onshoring—are redefining competitive positioning and investment priorities. The segmentation of that market demonstrates where gains are concentrated, particularly within injectable biologics and hospital or online pharmacy distribution channels.
Related Reports
Active Pharmaceutical Ingredients (API) Market: The Active Pharmaceutical Ingredients (API) Market Report Segments Into by Business Mode (Captive API, Merchant API), by Synthesis Type (Synthetic APIs, Biotech APIs), by Molecule Size (Small Molecule, Large Molecule), by Potency (High Potency, Low/Medium Potency), by Application (Oncology, Cardiovascular, and More), and Geography ( North America, Europe and More).
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
About the company: Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. For any inquiries or to access the full report, please contact: media@mordorintelligence.com https://www.mordorintelligence.com/
Contact Info:
Name: Jignesh Thakkar
Email: Send Email
Organization: Mordor Intelligence
Address: Hyderabad
Phone: +1617-765-2493
Website: https://www.mordorintelligence.com/
Release ID: 89172600
In the event of any inaccuracies, problems, or queries arising from the content shared in this press release, we encourage you to notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our diligent team will be readily available to respond and take swift action within 8 hours to rectify any identified issues or assist with removal requests. Ensuring the provision of high-quality and precise information is paramount to us.
